Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12608000276358
Ethics application status
Approved
Date submitted
29/05/2008
Date registered
29/05/2008
Date last updated
12/06/2018
Type of registration
Retrospectively registered

Titles & IDs
Public title
Treating spider phobia using Neuro Emotional Technqiue (N.E.T.): A pilot study
Scientific title
A randomised controlled trial using Neuro Emotional Technique (N.E.T.) compared to no intervention for treating adults aged 18 to 65 years with spider phobia as measured by the Subjective Units of Distress Scale (SUDS)
Secondary ID [1] 279942 0
NET for Spider Phobia
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
spider phobia 3203 0
Condition category
Condition code
Mental Health 3366 3366 0 0
Anxiety

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Neuro Emotional Technique (NET) is a relatively new stress-reduction technique whose aim is to remove neurological abnormalities which have a specified physiopathological pattern. Oftentimes emotional trauma can cause a learned emotional response, a conditioned fear, and as a result, a related physiopathological pattern. Under normal conditions, the learned response becomes extinct, and the physiopathological pattern resolves. However, occasionally this does not happen, and both persist. This especially seems to be case in phobia. The goal of NET is to normalise these aberrant patterns through a physical correction. It involves the dynamics of memory, muscle testing, and some principles of Traditional Chinese Medicine (i.e. the meridian-emotion relationship).
The experimental group received two 30-minute sessions of NET - once per week for 2 weeks.
Intervention code [1] 2951 0
Treatment: Other
Comparator / control treatment
No treatment
Control group
Active

Outcomes
Primary outcome [1] 4255 0
Mean change in Subjective Units of Distress Scale (SUDS) scores
Timepoint [1] 4255 0
At initial and final assessments (approximately 2 weeks later)
Secondary outcome [1] 7185 0
Mean change in Spider Questionnarie (SPQ) scores
Timepoint [1] 7185 0
At initial and final assessments (approximately 2 weeks later)
Secondary outcome [2] 7186 0
Mean change in Becks Anxiety Inventory (BAI) scores
Timepoint [2] 7186 0
At initial and final assessments (approximately 2 weeks later)
Secondary outcome [3] 7187 0
Mean change in heart rate
Timepoint [3] 7187 0
At initial and final assessments (approximately 2 weeks later)
Secondary outcome [4] 7188 0
Mean change in Behavioural Assessment Test (BAT) scores
Timepoint [4] 7188 0
At initial and final assessments (approximately 2 weeks later)

Eligibility
Key inclusion criteria
Self-reported spider phobia; fluent in English
Minimum age
18 Years
Maximum age
65 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Currently being treated for spider phobia; Currently have another disgnosed mental health condition

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Enrolment was via flyers, posters and general email between January and June 2007; group allocation was via sealed opaque envelope chosen by the participant following their initial assessment.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
15/01/2007
Actual
15/01/2007
Date of last participant enrolment
Anticipated
Actual
15/06/2007
Date of last data collection
Anticipated
Actual
30/06/2007
Sample size
Target
20
Accrual to date
Final
15
Recruitment outside Australia
Country [1] 993 0
United Kingdom
State/province [1] 993 0
Oxfordshire
Country [2] 10549 0
United States of America
State/province [2] 10549 0
Pennsylvania

Funding & Sponsors
Funding source category [1] 3437 0
Self funded/Unfunded
Name [1] 3437 0
Country [1] 3437 0
Primary sponsor type
University
Name
University of Oxford
Address
Department of Social Policy and Social Work
Barnett House, 32 Wellington Square, Oxford OX1 2ER, UK
Country
United Kingdom
Secondary sponsor category [1] 3079 0
None
Name [1] 3079 0
Address [1] 3079 0
Country [1] 3079 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 5461 0
Central University Research Ethics Committee
Ethics committee address [1] 5461 0
Ethics committee country [1] 5461 0
United Kingdom
Date submitted for ethics approval [1] 5461 0
Approval date [1] 5461 0
15/01/2007
Ethics approval number [1] 5461 0
SSD/CUREC2/07-007

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes
Attachments [1] 2772 2772 0 0
/AnzctrAttachments/82858-Phobia Paper JACM 12-09.pdf (Publication)

Contacts
Principal investigator
Name 28627 0
Dr Anne M Jensen
Address 28627 0
11A Whitemarsh Avenue
Erdenheim, PA 19038
USA
Country 28627 0
United States of America
Phone 28627 0
+1 323 744 7374
Fax 28627 0
Email 28627 0
dranne@drannejensen.com
Contact person for public queries
Name 11784 0
Dr. Anne M Jensen
Address 11784 0
11A Whitemarsh Avenue
Erdenheim, PA 19038
USA
Country 11784 0
United States of America
Phone 11784 0
+1 323 744 7374
Fax 11784 0
Email 11784 0
dranne@drannejensen.com
Contact person for scientific queries
Name 2712 0
Dr. Anne M Jensen
Address 2712 0
11A Whitemarsh Avenue
Erdenheim, PA 19038
USA
Country 2712 0
United States of America
Phone 2712 0
+1 323 744 7374
Fax 2712 0
Email 2712 0
dranne@drannejensen.com

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.